DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS
more
Trending: Pharmaceuticals & Science
Picture: picture alliance / Hendrik Schmidt/dpa
-
Media:
All
- Period:
- Period:Total
Asklepios Kliniken GmbH & Co. KGaA
Nomination period for the Broermann Medical Innovation Award started
Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is ...
moreLTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
moreNorgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
more
25Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality
more
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
more
25The Future of Nutrition: Dr. Clemens Röhrl on Regional Plant Research and Its Importance for Health and the Environment
moreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
more- 2
SHL Medical announces plans to establish SHL Advantec
more Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
moreFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
more
With Record Number of Nearly 10,000 Delegates and Visitors, IROS 2024 Successfully Concludes in Abu Dhabi
moreNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
moreGerman Federal Chancellor Scholz, WHO Director-General Dr Tedros and Bill Gates at the World Health Summit 2024 / The world's leading global health conference begins on October 13
Berlin (ots) - The financing of WHO, Germany's role in global health, antimicrobial resistance, Mpox, digitalization - topics like these are on the agenda of this year's World Health Summit from October 13-15 in Berlin. Leading international experts and decision-makers from all sectors will discuss strategies for a ...
moreGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
moreINST: Institut zur Erforschung und Förderung regionaler und transnationaler Kulturprozesse
22./23.9.2024: New York, Future Summit of United Nations / INST suggestions: New World Peace Order (new energy, new currency, new structures)
Vienna (ots) - INST was founded in 1994 by a group of scientists from the International Science Community. Today Sc.Dir. (Scientific Director) Dr. Herbert Arlt (Scientific Director and only legal representative of INST since 1994) coordinates about 25.000 colleagues from more than 150 countries. The main projects ...
more- 2
Cool Concept for International Logistics / Mannheim/Germany-based eutecma GmbH with Second Location in the USA
more
Germany Attracts Another Billion-Euro Pharma Project
Berlin (ots) - French pharmaceutical giant Sanofi has confirmed it will invest 1.3 billion euros to expand insulin production in the western German city of Frankfurt am Main. Sanofi says the expansion will encompass around 36,000 square meters – the equivalent of five football fields – on the company’s existing BioCampus site. It will go operational in 2029. The project is being supported by the German national ...
moreAustrian Innerio Group acquires automotive supplier ESTRA Europe
Kottingbrunn, Austria (ots) - - Expansion of expertise, competences, product and customer portfolio in line with growth strategy The Austrian automotive supplier Innerio, based in Kottingbrunn, Lower Austria, is acquiring the automotive supplier ESTRA Europe from the Chinese technology group Shanghai Aerospace Automobile Electromechanical as part of a share deal.ESTRA Europe generates an annual turnover of around 160 ...
moreGrünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...
more- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more ESSL - European Severe Storms Laboratory
Europe needs Twisters campaign
Wiener Neustadt, Austria (ots) - Researchers from all over Europe are organising high-density measurements of severe storms, similar to the new film Twisters. Severe weather researchers from 14 European countries want to work together to get to the bottom of severe thunderstorms so that they can provide better warnings in future. To this aim, they are currently planning the largest European measurement campaign on severe thunderstorms to date. "We want to use the latest ...
moreVirchow Foundation for Global Health
2Lucy Gilson and Johan Rockström awarded the Virchow Prize 2024
more
Revolutionary Partnership Announced: How Wandarra and PAPACKS® Aim to Turn the Tide on Plastic Waste in Australia
more- 10
Gerresheimer: New pictures available
more NTT DATA Business Solutions AG
International study shows: companies underestimate the lead time and complexity of digital transformation projects
moreNexans expands its ENERGYFLEX range of cables for solar installations with a new version offering unrivalled fire performance
moreInfineon receives German Brand Award for “Corporate Brand of the Year”
moreClenergy EV's network expands its network in Mainland Europe
more
Previous12345678910Next